Clinical Trial Update: Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne [Phase 3]

View source ↗

Summary

Phase 3 trial update on subject-reported outcomes with adapalene 0.3% plus benzoyl peroxide 2.5% in dark skin acne (Acne Vulgaris) with completed status and pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• adapalene 0.3% - benzoyl peroxide 2.5% (adapalene; benzoyl peroxide)

Snippet

Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2019-11-15